Ned Sharpless. NCI

Sharp­less out­lines FDA’s key pri­or­i­ties for ad­vanc­ing pub­lic health

Four months in­to his tenure, Act­ing FDA Com­mis­sion­er Ned Sharp­less sent an email to FDA staff on Tues­day out­lin­ing four main pri­or­i­ty ar­eas: as­sur­ing pub­lic health through emerg­ing tech­nolo­gies, in­vest­ing in the FDA’s next gen­er­a­tion ex­pert work­force and in­fra­struc­ture, mod­ern­iz­ing frame­works and pro­mot­ing and pro­tect­ing con­sumer and pa­tient safe­ty.

On the emerg­ing tech­nolo­gies front, Sharp­less dis­cussed how the FDA is try­ing to stay ahead of the curve while en­cour­ag­ing in­dus­try to adopt less cost­ly and more re­li­able ad­vanced man­u­fac­tur­ing plat­forms.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.